Literature DB >> 24835369

Generating a comprehensive set of standard operating procedures for a biorepository network-The CTRNet experience.

Rebecca Barnes1, Monique Albert, Sambasivarao Damaraju, Jean de Sousa-Hitzler, Sugy Kodeeswaran, Anne-Marie Mes-Masson, Peter Watson, Brent Schacter.   

Abstract

Despite the integral role of biorepositories in fueling translational research and the advancement of medicine, there are significant gaps in harmonization of biobanking practices, resulting in variable biospecimen collection, storage, and processing. This significantly impacts accurate downstream analysis and, in particular, creates a problem for biorepository networks or consortia. The Canadian Tumour Repository Network (CTRNet; www.ctrnet.ca ) is a consortium of Canadian tumor biorepositories that aims to enhance biobanking capacity and quality through standardization. To minimize the issue of variable biobanking practices throughout its network, CTRNet has developed and maintained a comprehensive set of 45 standard operating procedures (SOPs). There were four key elements to the CTRNet SOP development process: 1) an SOP development team was formed from members across CTRNet to co-produce each SOP; 2) a principal author was appointed with responsibility for overall coordination of the SOP development process; 3) the CTRNet Management Committee (composed of principal investigators for each member biorepository) reviewed/revised each SOP completed by the development team; and 4) external expert reviewers provided feedback and recommendations on each SOP. Once final Management Committee approval was obtained, the ratified SOP was published on the CTRNet website for public access. Since the SOPs were first published on the CTRNet website (June 2008), there have been approximately 15,000 downloads of one or more CTRNet SOPs/Policies by users from over 60 countries. In accordance with biobanking best practices, CTRNet performs an exhaustive review of its SOPs at set intervals, to coincide with each granting cycle. The last revision was completed in May 2012.

Entities:  

Mesh:

Year:  2013        PMID: 24835369     DOI: 10.1089/bio.2013.0061

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN: 1947-5543            Impact factor:   2.300


  3 in total

Review 1.  Enhancing translational research in paediatric rheumatology through standardization.

Authors:  Rae S M Yeung; Salvatore Albani; Brian M Feldman; Elizabeth Mellins; Berent Prakken; Lucy R Wedderburn
Journal:  Nat Rev Rheumatol       Date:  2016-09-22       Impact factor: 20.543

2.  Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report.

Authors:  Era L Pogosova-Agadjanyan; Anna Moseley; Megan Othus; Frederick R Appelbaum; Thomas R Chauncey; I-Ming L Chen; Harry P Erba; John E Godwin; Min Fang; Kenneth J Kopecky; Alan F List; Galina L Pogosov; Jerald P Radich; Cheryl L Willman; Brent L Wood; Soheil Meshinchi; Derek L Stirewalt
Journal:  Biopreserv Biobank       Date:  2017-11-27       Impact factor: 2.256

3.  Acquire: an open-source comprehensive cancer biobanking system.

Authors:  Heidi Dowst; Benjamin Pew; Chris Watkins; Apollo McOwiti; Jonathan Barney; Shijing Qu; Lauren B Becnel
Journal:  Bioinformatics       Date:  2015-01-07       Impact factor: 6.937

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.